No profile data available.
CV Sciences, Inc. (CVSI) is a healthcare company in the nutritional and natural health products industry, based in San Diego, United States, with about 42 full-time employees.
It reported revenue of $13.79 million for fiscal year 2025, down 12.2% from fiscal year 2024, and net income of -$958,000. In Q1 2026 (the quarter ended March 31, 2026) revenue was $3.20 million, down 11.4% from a year before. Its market capitalization was $2.26 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
CV Sciences, Inc. engages in the development, manufacture, marketing, and sale of herbal supplements, hemp-based cannabidiol (CBD), and plant-based food products in North America.
CV Sciences reported $13.79 million in revenue for fiscal year 2025, down 12.2% from $15.71 million in fiscal year 2024. In Q1 2026 revenue was $3.20 million.
$2.26 million as of October 9, 2026.
Listed companies of a similar size in the same industry (nutritional and natural health products) include Cyanotech Corporation (CYAN), cbdMD, Inc. (YCBD), NxGen Brands Inc. (NXGB), Agape ATP Corporation (ATPC).